Find the artificial intelligence based software for pathology that you are looking for. All products listed are available for the European market (CE-IVD marked).
The data presented in the pathology domain is under a publication embargo until May 2026 and should not be used for publication purposes until the embargo period has ended.
105 of 105 products
105/105
products
|
Sort by:
Subspeciality: Pulmonary pathology
Modality: Histopathology
Source: Public
No key features available
The uPath PD-L1 (SP263) image analysis, NSCLC algorithm is an adjunctive computer-assisted tool that identifies PD-L1 negative and positive tumor cells within a pathologist-annotated viable tumor region in images of formalin-fixed, paraffin-embedded neoplastic lung tissue.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
The uPath HER2 Dual ISH image analysis for Breast algorithm is intended for use as an aid to the pathologist to determine HER2 gene status by enumeration of the ratio of the HER2 gene to Chromosome 17, in formalin-fixed, paraffin-embedded neoplastic breast tissue specimens. When used with the VENTANA HER2 Dual ISH Assay, it is indicated as an aid in the assessment of breast cancer patients for whom Herceptin®(trastuzumab) treatment is being considered.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Vendor
Risk stratification
Stratipath Breast is an AI-based image analysis software intended for risk stratification of adult female breast cancer patients based on digital histological images. Stratipath Breast provides prognostic information through low-risk to high-risk classification levels that are associated with the patient’s risk of recurrence. The results are intended to help oncologists and pathologists assess the risk of relapse in early breast cancer patients.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
PANProfiler Breast is a breast cancer diagnostic software that reports tissue ER, PR and HER2 status by analyzing H&E slides. The software reduces the need for time-consuming lab tests while delivering biomarker status to patients, pathologists and multidisciplinary teams.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Prostate cancer grading
Paige Prostate Grade & Quantify is offered and sold as part of the Paige Prostate Suite. Categorizes areas suspicious for cancer by Gleason pattern, providing a primary and secondary Gleason grade prediction, as well as a percentage and linear measurement of tumor burden.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
No key features available
Paige Prostate Detect is a software only device intended to assist pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies prepared from hematoxylin & eosin (H&E) stained formalin-fixed paraffin embedded (FFPE) tissue. After initial diagnostic review of the WSI by the pathologist, if Paige Prostate detects tissue morphology suspicious for cancer, it provides coordinates (X,Y) on a single location on the image with the highest likelihood of having cancer for further review by the pathologist.
Subspeciality: Breast pathology
Modality: Histopathology
Source:
No key features available
Detects foci that are suspicious for breast cancer metastasis on WSI from lymph node specimens. If concerning morphology is detected, it indicates the foci suspicious for cancer. It is the responsibility of a qualified pathologist to employ appropriate procedures to assure the quality of the images.
Subspeciality: Breast pathology
Modality: Histopathology
Source:
Cancer detection, Cell classification, Tissue segmentation
Mindpeak Breast ER/PR is intended for in vitro diagnostic use as an aid to the pathologist in the assessment of samples from human breast cancer patients.
Subspeciality: Pulmonary pathology
Modality: Histopathology
Source:
No key features available
Lunit SCOPE PD-L1 assists in detecting and classifying PD-L1 biomarker expression by analyzing digitized IHC whole slide images from formalin-fixed paraffin embedded (FFPE) tissue.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Prostate cancer detection, Prostate cancer grading
HALO Prostate AI, from Indica Labs, is a CE-IVD certified deep learning based screening tool designed to assist pathologists in the identification and grading of prostate cancer in core needle biopsies. The algorithm automatically analyzes all appropriate case slides and notifies pathologists of cases with suspected findings directly in their native workflow.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Gleason grading , High-grade PIN detection, Perineural invasion detection, Prostate cancer detection
Ibex Prostate assists pathologists in the diagnosis of prostate biopsies by improving the detection and grading of cancer and clinically relevant features, and enabling multiple automated decision support and reporting tools. The AI model detects 19 tissue morphologies. Ibex Prostate is aimed at:
• Triaging with tagged case-level and slide-level AI findings
• Detecting cancer, perineural invasion, high-grade PIN, inflammation, atrophy, and more
• Gleason grading and heatmaps
• Automatic tissue and tumor length measurements
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
Using digitized images of HER2 IHC stained breast cancer samples, Ibex’s breast HER2 solution detects invasive tumor cell staining patterns and classifies HER2 expression into four standard scores: 0, 1+, 2+ and 3+ (based on ASCO/CAP guidelines). It can assist pathologists in the detection and interpretation of cases with HER2 ultralow expression (defined as IHC 0 with membrane staining present).
